BiVictriX Therapeutics plc

AIM:BVX Stock Report

Market Cap: UK£8.3m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

BiVictriX Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of BVX?
Owner TypeNumber of SharesOwnership Percentage
Private Companies4,333,3255.25%
Individual Insiders11,919,58514.4%
General Public16,389,24819.9%
VC/PE Firms18,682,28922.6%
Institutions31,201,64137.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 77.89% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.4%
Development Bank of Wales Plc
11,870,021UK£1.2m0%17.6%
11.6%
Robert Keith
9,562,434UK£956.2k-0.93%no data
8.25%
BioCity Investments Ltd
6,812,268UK£681.2k0%100.0%
6.71%
Canaccord Genuity Asset Management Limited
5,538,424UK£553.8k-39%0.02%
5.8%
Canaccord Genuity Wealth (International) Limited
4,787,663UK£478.8k0%0.01%
5.22%
Alden AS
4,307,692UK£430.8k115%no data
3.65%
Spreadex.com Limited, Asset Management Arm
3,014,037UK£301.4k-11.1%0.81%
3.25%
Cantor Fitzgerald Asset Management
2,678,622UK£267.9k87.5%0.01%
2.77%
British Patient Capital Limited
2,284,527UK£228.5k0%no data
2.46%
Kredietrust Luxembourg SA
2,032,808UK£203.3k0%0.01%
1.98%
Tiffany Thorn
1,632,500UK£163.2k0%no data
1.44%
Jarvis Securities plc, Asset Management Arm
1,185,260UK£118.5k-6.82%0.01%
1.31%
O2h Ventures Limited
1,080,000UK£108.0k0%no data
1.21%
Banque Internationale a Luxembourg SA, Asset Management Arm
1,000,000UK£100.0k0%0.04%
1.2%
Charles Stanley & Co. Ltd, Asset Management Arm
994,000UK£99.4k49.7%no data
0.98%
Killik Asset Management
811,526UK£81.2k0%no data
0.9%
Brewin Dolphin Limited
745,000UK£74.5k0%no data
0.8%
Panmure Gordon & Co. Ltd., Asset Management Arm
656,513UK£65.7k513%0.09%
0.73%
London Wealth Management Limited
605,770UK£60.6k0%no data
0.73%
Close Asset Management Ltd.
600,060UK£60.0k-7.04%no data
0.69%
M. D. Barnard & Co. Ltd., Asset Management Arm
566,031UK£56.6k25.6%0.06%
0.61%
Citigroup Inc.,Banking and Securities Investments
500,000UK£50.0k0%no data
0.47%
IG Group Holdings Plc, Asset Management Arm
389,588UK£39.0k552%no data
0.39%
Robert Hawkins
325,000UK£32.5k44.4%no data
0.36%
Raymond James Financial Inc., Asset Management Arm
300,000UK£30.0k33.3%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/09/10 12:58
End of Day Share Price 2024/09/10 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BiVictriX Therapeutics plc is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael MitchellPanmure Liberum Historic (Panmure Gordon)